These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 31585633)
1. Combined treatment with cisplatin and the tankyrase inhibitor XAV-939 increases cytotoxicity, abrogates cancer-stem-like cell phenotype and increases chemosensitivity of head-and-neck squamous-cell carcinoma cells. Roy S; Roy S; Kar M; Chakraborty A; Kumar A; Delogu F; Asthana S; Hande MP; Banerjee B Mutat Res Genet Toxicol Environ Mutagen; 2019 Oct; 846():503084. PubMed ID: 31585633 [TBL] [Abstract][Full Text] [Related]
2. Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma. Roy S; Roy S; Kar M; Padhi S; Saha A; Anuja K; Banerjee B J Oral Pathol Med; 2018 May; 47(5):492-501. PubMed ID: 29575240 [TBL] [Abstract][Full Text] [Related]
3. p38 Mitogen-activated protein kinase modulates cisplatin resistance in Head and Neck Squamous Cell Carcinoma cells. Roy S; Roy S; Anuja K; Thakur S; Akhter Y; Padhi S; Banerjee B Arch Oral Biol; 2021 Feb; 122():104981. PubMed ID: 33302041 [TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition. Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877 [TBL] [Abstract][Full Text] [Related]
5. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway. Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717 [TBL] [Abstract][Full Text] [Related]
6. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells. Moon JH; Lee SH; Koo BS; Kim JM; Huang S; Cho JH; Eun YG; Shin HA; Lim YC Oral Oncol; 2020 Dec; 111():104948. PubMed ID: 32771963 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma. Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of CD44 sensitizes cisplatin-resistance and affects Wnt/β-catenin signaling in HNSCC cells. Roy S; Kar M; Roy S; Padhi S; Kumar A; Thakur S; Akhter Y; Gatto G; Banerjee B Int J Biol Macromol; 2020 Apr; 149():501-512. PubMed ID: 31953176 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma. Liu S; Qin Z; Mao Y; Wang N; Zhang W; Wang Y; Chen Y; Jia L; Peng X Theranostics; 2024; 14(2):622-639. PubMed ID: 38169606 [No Abstract] [Full Text] [Related]
10. Broccoli extract increases drug-mediated cytotoxicity towards cancer stem cells of head and neck squamous cell carcinoma. Elkashty OA; Tran SD Br J Cancer; 2020 Oct; 123(9):1395-1403. PubMed ID: 32773768 [TBL] [Abstract][Full Text] [Related]
11. Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous Carcinoma. Keysar SB; Gomes N; Miller B; Jackson BC; Le PN; Morton JJ; Reisinger J; Chimed TS; Gomez KE; Nieto C; Frederick B; Pronk GJ; Somerset HL; Tan AC; Wang XJ; Raben D; Su TT; Jimeno A Cancer Res; 2020 Mar; 80(5):1183-1198. PubMed ID: 31911553 [TBL] [Abstract][Full Text] [Related]
12. Ectopic overexpression of CD133 in HNSCC makes it resistant to commonly used chemotherapeutics. Lee J; Park M; Ko Y; Kim B; Kim O; Hyun H; Kim D; Sohn H; Moon YL; Lim W Tumour Biol; 2017 Apr; 39(4):1010428317695534. PubMed ID: 28381190 [TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal transition and cancer stem cells: A route to acquired cisplatin resistance through epigenetics in HNSCC. Lima de Oliveira J; Moré Milan T; Longo Bighetti-Trevisan R; Fernandes RR; Machado Leopoldino A; Oliveira de Almeida L Oral Dis; 2023 Jul; 29(5):1991-2005. PubMed ID: 35403781 [TBL] [Abstract][Full Text] [Related]
14. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell. Lim YC; Kang HJ; Moon JH Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851 [TBL] [Abstract][Full Text] [Related]
15. Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway. Wu X; Luo F; Li J; Zhong X; Liu K Int J Oncol; 2016 Apr; 48(4):1333-40. PubMed ID: 26820603 [TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma. Bourguignon LY; Wong G; Shiina M J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro. Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460 [TBL] [Abstract][Full Text] [Related]
19. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt. Kuo SZ; Blair KJ; Rahimy E; Kiang A; Abhold E; Fan JB; Wang-Rodriguez J; Altuna X; Ongkeko WM BMC Cancer; 2012 Nov; 12():556. PubMed ID: 23176396 [TBL] [Abstract][Full Text] [Related]
20. Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma. Roy S; Kar M; Roy S; Saha A; Padhi S; Banerjee B Cell Oncol (Dordr); 2018 Apr; 41(2):185-200. PubMed ID: 29243047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]